Table 1.
Cell line | Doubling time (h) |
---|---|
UROtsa | 42 ± 1.9 |
URO-MSC, 12 weeks | 27 ± 0.3* |
URO-MSC, 24 weeks | 25 ± 0.2* |
URO-MSC, 52 weeks | 21 ± 0.2* |
UROtsa were continuously exposed to 0.05 μM MMAIII for 12, 24, and 52 weeks. Trypan blue exclusion assay was used to enumerate cells at 24, 48, 72, and 96 h after plating. Then, growth curves were generated and used to estimate doubling times of treated and untreated cells. Data represent results from one experiment (n = 3). ANOVA followed by Bonferroni’s multiple comparisons test was used to identify significant changes in doubling time.
Significant deviations from control cells (P < 0.05) were marked with an asterisk.